Alternating Hemiplegia of Childhood: A Study of 10 Patients and Results of Flunarizine Treatment

Silver K, Andermann F. “Alternating Hemiplegia of Childhood: A Study of 10 Patients and Results of Flunarizine Treatment.” Neurology 43, no. 1 (January 1993): 36-41.

Sone K, Oguni H, Katsumori H, Funatsuka M, Tanaka T, Osawa M. “Successful Trial of Amantadine Hydrochloride for Two Patients with Alternating Hemiplegia of Childhood.” Neuropediatrics 31, no. 6 (December 2000): 307-309.

Veneselli E, Biancheri R. “Alternating Hemiplegia of Childhood: Treatment of Attacks with Chloral Hydrate and Niaprazine.” European Journal of Pediatrics 156, no. 2 (February 1997): 157-158.

Ju J, Hirose S, Shi XY, Ishii A, Hu LY, Zou LP. “Treatment with Oral ATP Decreases Alternating Hemiplegia of Childhood with de Novo ATP1A3 Mutation.” Orphanet Journal of Rare Disease 11, no. 1 (May 2016).

Kasinathan A, Sharawat IK, Sahu JK, Sankhyan N. “Topiramate Therapy in Alternating Hemiplegia of Childhood.” Indian Journal of Pediatrics. 2017 Dec; 84;(12): 957-958.

Kwon YJ, Falk MJ, Bennett MJ. “Flunarizine rescues reduced Lifespan in CLN3 Triple Knock-out Caenorhabditis Elegans Model of Batten Disease.” Journal of Inherited Metabolic Disease (October 20, 2016).

Lai KL, Niddam DM, Fuh JL, Chen SP, Wang YF, Chen WT, Wu JC, Wang SJ. “Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis: A Randomized Trial.” Acta Neurologica Scandinavica (June 16, 2016).

Mohamed BP, Goadsby J, Prabhakar P. “Safety and Efficacy of Flunarizine in Childhood Migraine: 11 Years’ Experience, with Emphasis on its Effect in Hemiplegic Migraine.” Developmental Medicine & Child Neurology (January 23, 2012).

Pledger GW. “Flunarizine for Treatment of Partial Seizures: Results of a Concentration-Controlled Trial.” Neurology 44, no.10 (1994): 1830-1836.

Sasaki M, Ishii A, Saito Y, Morisada N, et al. “Genotype-Phenotype Correlations in Alternating Hemiplegia of Childhood.” Neurology (January 15, 2014).